Firmenbeschreibung
Unter dem Schirm der Carl Zeiss Meditec AG sind die Medizintechnik-Aktivitäten von ZEISS gebündelt. Das Unternehmen ist einer der weltweit führenden Medizintechnik-Anbieter. Die Gesellschaft bietet Lösungen für die Zukunftsmärkte Medical and Research Solutions, Industrial Solutions, Eye Care und Lifestyle Products an und trägt mit Innovationen in der Augenheilkunde und Mikrochirurgie zum medizinischen Fortschritt bei. Das Unternehmen entwickelt und vertreibt Operationsmikroskope, ophthalmologische Diagnosesysteme, Mikroskope, Lithografieoptik, industrielle Messtechnik, Brillengläser, Planetariumstechnik, optronische Produkte, Film- und Fotoobjektive sowie Ferngläser und Spektive. Ärzte in aller Welt bekommen mit Zeiss-Meditec-Technologien intelligente Werkzeuge an die Hand, um die vier wesentlichen Krankheitsbilder des Auges, Fehlsichtigkeit (Refraktion), Grauer Star (Katarakt), Grüner Star (Glaukom) und Netzhauterkrankungen (Retina-Erkrankungen), effizient und wirksam zu behandeln und bietet dabei Produkte von der Diagnose über die Therapie bis hin zur Nachbehandlung. Darüber hinaus bietet der Konzern neben Operationsmikroskopen auch Visualisierungslösungen für die HNO- und Neurochirurgie. Die Produkte werden dabei in erster Linie bei der Entfernung von Tumoren, der Behandlung von Gefäßerkrankungen und bei der Therapie funktioneller Krankheiten eingesetzt.
KeyData
| endOfFinancialYear: | 30.09.2023 00:00 |
| stockholderStructure: | Carl Zeiss AG (59.1%),free float (38.7%),treasury shares (2.1%) |
| sharesOutstanding: | 89450570.0000 |
| ceo: | Dr. Markus Weber |
| board: | Justus Felix Wehmer |
| supervisoryBoard: | Dr. Karl Lamprecht, Renè Denner, Isabel De Paoli, Tanja von der Goltz, Peter Kameritsch, Dr. Christian Müller, Torsten Reitze, Brigitte Koblizek, Jeffrey Marx , Heike Madan, Falk Bindheim, Dr. Christian Münster, Prof. Dr. Michael Kaschke |
| countryID: | 2 |
| freeFloat: | 40.9000 |
| faceValue: | 1.0000 |
| faceValueCurrencyID: | 1 |
| faceValueCurrency: | EUR |
| sectorName: | Medizintechnische Produkte |
| industryName: | Gesundheitswesen |
| subsectorName: | Hochentwickelte medizinische Geräte |
| country: | Deutschland |
| countryName: | Deutschland |
Kontakt
| name: | Sebastian Frericks |
| phone: | +49-3641-220-116 |
| fax: | +49-3641-220-117 |
| email: | investors.meditec@zeiss.com |
| irWebSite: | https://www.zeiss.com/meditec-ag/investor-relations.html#contact |
Adresse
| street: | Göschwitzer Straße 51-52 |
| city: | D-07745 Jena |
| phone: | +49-3641-220-0 |
| fax: | +49 3641 220 112 |
| webSite: | zeiss.de/corporate/home.html |
| email: | info@meditec.zeiss.com |
Finanzen (kurz)
| year: | 2022 | cash: | 7.7300 |
| balanceSheetTotal: | 2822.8200 | liabilities: | 792.7300 |
| totalShareholdersEquity: | 2015.1000 | sales: | 1902.8400 |
| investment: | 13.2500 | incomeBeforeTaxes: | 403.4900 |
| netIncome: | 293.9000 | employees: | 4224 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
| year: | 2023 | cash: | 10.6000 |
| balanceSheetTotal: | 3032.9000 | liabilities: | 860.0100 |
| totalShareholdersEquity: | 2159.4000 | sales: | 2089.3000 |
| investment: | 28.1000 | incomeBeforeTaxes: | 412.6000 |
| netIncome: | 290.4000 | employees: | 4823 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
| year: | 2024 | cash: | 20.2800 |
| balanceSheetTotal: | 3393.2000 | liabilities: | 1336.7100 |
| totalShareholdersEquity: | 2041.6900 | sales: | 2066.1200 |
| investment: | 22.3900 | incomeBeforeTaxes: | 240.8600 |
| netIncome: | 178.7200 | employees: | 5730 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
Finanzen (kurz)
| year: | 2022 |
| cash: | 7.7300 |
| balanceSheetTotal: | 2822.8200 |
| liabilities: | 792.7300 |
| totalShareholdersEquity: | 2015.1000 |
| sales: | 1902.8400 |
| investment: | 13.2500 |
| incomeBeforeTaxes: | 403.4900 |
| netIncome: | 293.9000 |
| employees: | 4224 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
| year: | 2023 |
| cash: | 10.6000 |
| balanceSheetTotal: | 3032.9000 |
| liabilities: | 860.0100 |
| totalShareholdersEquity: | 2159.4000 |
| sales: | 2089.3000 |
| investment: | 28.1000 |
| incomeBeforeTaxes: | 412.6000 |
| netIncome: | 290.4000 |
| employees: | 4823 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
| year: | 2024 |
| cash: | 20.2800 |
| balanceSheetTotal: | 3393.2000 |
| liabilities: | 1336.7100 |
| totalShareholdersEquity: | 2041.6900 |
| sales: | 2066.1200 |
| investment: | 22.3900 |
| incomeBeforeTaxes: | 240.8600 |
| netIncome: | 178.7200 |
| employees: | 5730 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
Finanzen (ausführlich)
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 3032.9000 | cash: | 10.6000 |
| currentAssets: | 1911.7000 | fixedAssets: | 1121.2000 |
| liabilities: | 561.6000 | nonCurrentLiabilities: | 298.4000 |
| totalLiabilitiesEquity: | 3032.9000 | provisions: | 71.6000 |
| totalShareholdersEquity: | 2159.4000 | employees: | 4823 |
| property: | 315.8000 | intangibleAssets: | 259.5000 |
| longTermInvestments: | 8.6000 | inventories: | 520.2000 |
| accountsReceivable: | 196.6000 | accountsPayable: | 157.8000 |
| liabilitiesTotal: | 860.0100 | longTermDebt: | 229.9000 |
| shortTermDebt: | 46.0000 | minorityInterests: | 13.5000 |
| sales: | 2089.3000 | netIncome: | 290.4000 |
| operatingResult: | 348.1000 | incomeInterest: | 12.8000 |
| investments: | 349.3000 | incomeTaxes: | 120.6000 |
| costGoodsSold: | 883.5000 | grossProfit: | 1205.8000 |
| minorityInterestsProfit: | -1.6000 | revenuePerEmployee: | 433195.1068 |
| cashFlow: | 250.9000 | cashFlowInvesting: | -111.0000 |
| cashFlowFinancing: | -135.1000 | accountingStandard: | IFRS |
| equityRatio: | 71.1992 | debtEquityRatio: | 40.4511 |
| liquidityI: | 1.8875 | liquidityII: | 36.8946 |
| netMargin: | 13.8994 | grossMargin: | 57.7131 |
| cashFlowMargin: | 12.0088 | ebitMargin: | 16.6611 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 19.1072 |
| preTaxROA: | 13.6041 | roe: | 13.4482 |
| roa: | 9.5750 | netIncomeGrowth: | -1.1909 |
| revenuesGrowth: | 9.7990 | taxExpenseRate: | 29.2293 |
| equityTurnover: | 0.9675 | epsBasic: | 3.2500 |
| epsBasicGrowth: | -1.2158 | incomeBeforeTaxes: | 412.6000 |
| priceEarningsRatioCompany: | 25.4831 | priceCashFlowRatio: | 29.5236 |
| dividendYield: | 1.3282 | bookValuePerShare: | 24.1434 |
| marketCap: | 7407468007.4000 | earningsYield: | 3.9242 |
| pegRatio: | -20.9598 | cashFlowPerShare: | 2.8052 |
| netAssetsPerShare: | 24.2943 | priceBookValueRatio: | 3.4303 |
| dividendsPerShare: | 1.1000 | priceEarningsRatio: | 25.5078 |
| netEarningsPerShare: | 3.2468 | currency: | EUR |
| year: | 2024 | units: | 1000000 |
| balanceSheetTotal: | 3393.2000 | cash: | 20.2800 |
| currentAssets: | 1212.4800 | fixedAssets: | 2180.7100 |
| liabilities: | 568.8300 | nonCurrentLiabilities: | 767.8800 |
| totalLiabilitiesEquity: | 3393.2000 | provisions: | 358.2400 |
| totalShareholdersEquity: | 2041.6900 | employees: | 5730 |
| property: | 353.7600 | intangibleAssets: | 706.8500 |
| longTermInvestments: | 20.3700 | inventories: | 536.5500 |
| accountsReceivable: | 209.0500 | accountsPayable: | 110.5500 |
| liabilitiesTotal: | 1336.7100 | longTermDebt: | 458.8900 |
| shortTermDebt: | 19.1100 | minorityInterests: | 14.7800 |
| sales: | 2066.1200 | netIncome: | 178.7200 |
| operatingResult: | 194.4500 | incomeInterest: | -7.0300 |
| investments: | 343.0800 | incomeTaxes: | 60.7100 |
| costGoodsSold: | 977.4900 | grossProfit: | 1088.6300 |
| minorityInterestsProfit: | 1.4200 | revenuePerEmployee: | 360579.4066 |
| cashFlow: | 247.3100 | cashFlowInvesting: | -412.3000 |
| cashFlowFinancing: | 176.2400 | accountingStandard: | IFRS |
| equityRatio: | 60.1700 | debtEquityRatio: | 0.0000 |
| liquidityI: | 3.5652 | liquidityII: | 40.3161 |
| netMargin: | 8.6500 | grossMargin: | 52.6896 |
| cashFlowMargin: | 11.9698 | ebitMargin: | 9.4114 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 11.7971 |
| preTaxROA: | 7.0983 | roe: | 8.7535 |
| roa: | 5.2670 | netIncomeGrowth: | -38.4573 |
| revenuesGrowth: | -1.1095 | taxExpenseRate: | 25.2055 |
| equityTurnover: | 1.0120 | epsBasic: | 2.0100 |
| epsBasicGrowth: | -38.1538 | incomeBeforeTaxes: | 240.8600 |
| dividendsPerShare: | 0.6000 | currency: | EUR |
| year: | 2025 | priceEarningsRatioCompany: | 25.3483 |
| priceCashFlowRatio: | 18.4283 | dividendYield: | 1.1776 |
| bookValuePerShare: | 22.8248 | marketCap: | 4557506541.5000 |
| earningsYield: | 3.9450 | pegRatio: | -0.6644 |
| cashFlowPerShare: | 2.7648 | netAssetsPerShare: | 22.8248 |
| priceBookValueRatio: | 2.2322 | priceEarningsRatio: | 25.5008 |
| netEarningsPerShare: | 1.9980 | currency: | EUR |
Finanzen (ausführlich)
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 3032.9000 |
| cash: | 10.6000 |
| currentAssets: | 1911.7000 |
| fixedAssets: | 1121.2000 |
| liabilities: | 561.6000 |
| nonCurrentLiabilities: | 298.4000 |
| totalLiabilitiesEquity: | 3032.9000 |
| provisions: | 71.6000 |
| totalShareholdersEquity: | 2159.4000 |
| employees: | 4823 |
| property: | 315.8000 |
| intangibleAssets: | 259.5000 |
| longTermInvestments: | 8.6000 |
| inventories: | 520.2000 |
| accountsReceivable: | 196.6000 |
| accountsPayable: | 157.8000 |
| liabilitiesTotal: | 860.0100 |
| longTermDebt: | 229.9000 |
| shortTermDebt: | 46.0000 |
| minorityInterests: | 13.5000 |
| sales: | 2089.3000 |
| netIncome: | 290.4000 |
| operatingResult: | 348.1000 |
| incomeInterest: | 12.8000 |
| investments: | 349.3000 |
| incomeTaxes: | 120.6000 |
| costGoodsSold: | 883.5000 |
| grossProfit: | 1205.8000 |
| minorityInterestsProfit: | -1.6000 |
| revenuePerEmployee: | 433195.1068 |
| cashFlow: | 250.9000 |
| cashFlowInvesting: | -111.0000 |
| cashFlowFinancing: | -135.1000 |
| accountingStandard: | IFRS |
| equityRatio: | 71.1992 |
| debtEquityRatio: | 40.4511 |
| liquidityI: | 1.8875 |
| liquidityII: | 36.8946 |
| netMargin: | 13.8994 |
| grossMargin: | 57.7131 |
| cashFlowMargin: | 12.0088 |
| ebitMargin: | 16.6611 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 19.1072 |
| preTaxROA: | 13.6041 |
| roe: | 13.4482 |
| roa: | 9.5750 |
| netIncomeGrowth: | -1.1909 |
| revenuesGrowth: | 9.7990 |
| taxExpenseRate: | 29.2293 |
| equityTurnover: | 0.9675 |
| epsBasic: | 3.2500 |
| epsBasicGrowth: | -1.2158 |
| incomeBeforeTaxes: | 412.6000 |
| priceEarningsRatioCompany: | 25.4831 |
| priceCashFlowRatio: | 29.5236 |
| dividendYield: | 1.3282 |
| bookValuePerShare: | 24.1434 |
| marketCap: | 7407468007.4000 |
| earningsYield: | 3.9242 |
| pegRatio: | -20.9598 |
| cashFlowPerShare: | 2.8052 |
| netAssetsPerShare: | 24.2943 |
| priceBookValueRatio: | 3.4303 |
| dividendsPerShare: | 1.1000 |
| priceEarningsRatio: | 25.5078 |
| netEarningsPerShare: | 3.2468 |
| currency: | EUR |
| year: | 2024 |
| units: | 1000000 |
| balanceSheetTotal: | 3393.2000 |
| cash: | 20.2800 |
| currentAssets: | 1212.4800 |
| fixedAssets: | 2180.7100 |
| liabilities: | 568.8300 |
| nonCurrentLiabilities: | 767.8800 |
| totalLiabilitiesEquity: | 3393.2000 |
| provisions: | 358.2400 |
| totalShareholdersEquity: | 2041.6900 |
| employees: | 5730 |
| property: | 353.7600 |
| intangibleAssets: | 706.8500 |
| longTermInvestments: | 20.3700 |
| inventories: | 536.5500 |
| accountsReceivable: | 209.0500 |
| accountsPayable: | 110.5500 |
| liabilitiesTotal: | 1336.7100 |
| longTermDebt: | 458.8900 |
| shortTermDebt: | 19.1100 |
| minorityInterests: | 14.7800 |
| sales: | 2066.1200 |
| netIncome: | 178.7200 |
| operatingResult: | 194.4500 |
| incomeInterest: | -7.0300 |
| investments: | 343.0800 |
| incomeTaxes: | 60.7100 |
| costGoodsSold: | 977.4900 |
| grossProfit: | 1088.6300 |
| minorityInterestsProfit: | 1.4200 |
| revenuePerEmployee: | 360579.4066 |
| cashFlow: | 247.3100 |
| cashFlowInvesting: | -412.3000 |
| cashFlowFinancing: | 176.2400 |
| accountingStandard: | IFRS |
| equityRatio: | 60.1700 |
| debtEquityRatio: | 0.0000 |
| liquidityI: | 3.5652 |
| liquidityII: | 40.3161 |
| netMargin: | 8.6500 |
| grossMargin: | 52.6896 |
| cashFlowMargin: | 11.9698 |
| ebitMargin: | 9.4114 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 11.7971 |
| preTaxROA: | 7.0983 |
| roe: | 8.7535 |
| roa: | 5.2670 |
| netIncomeGrowth: | -38.4573 |
| revenuesGrowth: | -1.1095 |
| taxExpenseRate: | 25.2055 |
| equityTurnover: | 1.0120 |
| epsBasic: | 2.0100 |
| epsBasicGrowth: | -38.1538 |
| incomeBeforeTaxes: | 240.8600 |
| dividendsPerShare: | 0.6000 |
| currency: | EUR |
| year: | 2025 |
| priceEarningsRatioCompany: | 25.3483 |
| priceCashFlowRatio: | 18.4283 |
| dividendYield: | 1.1776 |
| bookValuePerShare: | 22.8248 |
| marketCap: | 4557506541.5000 |
| earningsYield: | 3.9450 |
| pegRatio: | -0.6644 |
| cashFlowPerShare: | 2.7648 |
| netAssetsPerShare: | 22.8248 |
| priceBookValueRatio: | 2.2322 |
| priceEarningsRatio: | 25.5008 |
| netEarningsPerShare: | 1.9980 |
| currency: | EUR |
